CRESCENT BIOPHARMA, INC. (CBIO) Insider Trading

Name: CRESCENT BIOPHARMA, INC. (CBIO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 18, 2026): Ryan Lynch (Treasurer, Senior Vice President of Finance and Chief Accounting Officer): Sale of 240 shares, $4.3K.

Get alerted when insiders trade CBIO

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta